ERAS (STOCKS)
Erasca, Inc. Common Stock
$16.590000
-0.420000 (-2.47%)
Prev close: $17.010000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Jonathan E. Lim
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $5,062.93M
- Employees
- 129
- P/E (TTM)
- -37.13
- P/B (TTM)
- 14.86
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
5
Strong Buy
9
Buy
2
Hold
1
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-0.10 | $-0.11 | +0.0091 | +8.34% |
|
Sep 2025 (Q3)
|
$-0.11 | $-0.11 | -0.0046 | -4.36% |
|
Jun 2025 (Q2)
|
$-0.12 | $-0.11 | -0.0078 | -6.95% |
|
Mar 2025 (Q1)
|
$-0.11 | $-0.13 | +0.0185 | +14.40% |
Financial Statements
| Revenues | $0.00 |
| Nonoperating Income/Loss | $16.36M |
| Operating Expenses | $140.91M |
| Operating Income/Loss | -$140.91M |
| Income/Loss From Continuing Operations After Tax | -$124.55M |
| Income/Loss From Continuing Operations Before Tax | -$124.55M |
| Income Tax Expense/Benefit | $0.00 |
| Net Income/Loss | -$124.55M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$124.55M |
| Net Income/Loss Available To Common Stockholders, Basic | -$124.55M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.44 |
| Diluted Earnings Per Share | -$0.44 |
| Basic Average Shares | 283,533,696 |
| Diluted Average Shares | 283,533,696 |
| Assets | $396.15M |
| Current Assets | $286.24M |
| Cash | $341.80M |
| Noncurrent Assets | $109.92M |
| Fixed Assets | $13.30M |
| Other Non-current Assets | $96.61M |
| Liabilities | $70.98M |
| Current Liabilities | $28.51M |
| Accounts Payable | $981.00K |
| Other Current Liabilities | $27.53M |
| Noncurrent Liabilities | $42.47M |
| Equity | $325.17M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $325.17M |
| Liabilities And Equity | $396.15M |
| Net Cash Flow From Operating Activities | -$95.46M |
| Net Cash Flow From Operating Activities, Continuing | -$95.46M |
| Net Cash Flow From Investing Activities | $100.43M |
| Net Cash Flow From Investing Activities, Continuing | $100.43M |
| Net Cash Flow From Financing Activities | $1.10M |
| Net Cash Flow From Financing Activities, Continuing | $1.10M |
| Net Cash Flow | $6.07M |
| Net Cash Flow, Continuing | $6.07M |
| Comprehensive Income/Loss | -$124.32M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$124.32M |
| Other Comprehensive Income/Loss | $223.00K |